NSE: JYOTHYLAB · BSE: 532926
JYOTHY LABS LIMITED
Makes and sells branded household and personal care products in India across five categories. Fabric Care, the largest at 45.7% of segment revenue, sells detergent bars, powders and liquid detergents for washing clothes. Dishwashing at 32.6% covers dishwash bars and liquids and was anchored by the Pril licensed brand until Henkel declined to renew the license on 31 May 2026; Exo is being repositioned as the lead dishwash brand. Personal Care at 10.9% covers soaps and personal wash products, Household Insecticides at 6.7% covers mosquito coils and liquid vapourisers, and Others at 4.2% covers smaller categories. Costs are dominated by raw materials at 50% of revenue, largely crude-linked surfactants and packaging, and a ~4% blended price increase was taken in March 2026 to offset input inflation. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Fabric Care (46%), Dishwashing (33%), Personal Care (11%), Household Insecticides (7%), Others (4%). Diversified Indian FMCG selling branded household and personal care products across five categories
Exhibit 1: Financial summary, FY21–FY25 (all audited; no estimate years)
| ₹ crore · consolidated | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 1,909 | 2,196 | 2,486 | 2,757 | 2,847 |
| EBITDA (ex other income) | 291 | 248 | 323 | 480 | 495 |
| margin % | 15.2 | 11.3 | 13.0 | 17.4 | 17.4 |
| Owners' profit | 199 | 162 | 240 | 368 | 368 |
| EPS, as reported (₹) | 5.43 | 4.41 | 6.53 | 10.06 | 10.09 |
| ROE % · ROCE % | 13.7 · 17.1 | 11.3 · 13.9 | 15.5 · 18.9 | 20.4 · 25.2 | 18.1 · 22.7 |
| Debt / equity (x) | 0.08 | 0.09 | 0.00 | 0.00 | 0.00 |
| Cash from operations | 402 | 203 | 329 | 458 | 311 |
| Capex | (26) | (26) | (35) | (37) | (58) |
Exhibit 2: Quarterly performance, last 8 quarters
| ₹ crore | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 687 | 732 | 678 | 660 | 742 | 734 | 704 | 667 |
| Profit before tax | 121 | 135 | 115 | 107 | 132 | 136 | 114 | 107 |
| Net profit | 96 | 104 | 91 | 78 | 102 | 105 | 87 | 76 |
| EPS (₹) | 2.62 | 2.84 | 2.48 | 2.13 | 2.77 | 2.86 | 2.38 | 2.08 |
Exhibit 3: Segment revenue, FY25
| Segment | Revenue, ₹ crore | Share % |
|---|---|---|
| Fabric Care | 1,249 | 43.9 |
| Dishwashing | 972 | 34.1 |
| Household Insecticides | 103 | 3.6 |
| Personal Care | 212 | 7.4 |
| Others | 123 | 4.3 |
| Household Insecticieds | 45 | 1.6 |
| Household insecticides | 50 | 1.8 |
| Personal care | 93 | 3.3 |
| Total, before eliminations | 2,847 | 100.0 |
Exhibit 4: Peers — basic industry group, by market cap
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| JYOTHY LABS LIMITED ◆ | 6,419 | 17.3 | 3.13 | 11.5 | 18.1 | 22.4 | 10.7 | 18.5 |
| EVEREADY INDS. IND. LTD. | 2,217 | 12.4 | 3.56 | 11.1 | 27.5 | 21.4 | 3.1 | 15.1 |
| HIGH ENERGY BATTERIES (INDIA) | 487 | 31.7 | 4.37 | — | 13.8 | 18.0 | — | 37.3 |
| INDO-NATIONAL LIMITED | 226 | — | 0.73 | — | (8.7) | (7.8) | (3.2) | 0.9 |
| PANASONIC ENERGY INDIA COMPANY | 174 | 49.9 | 1.69 | — | 3.4 | 5.2 | — | 5.9 |
| PEE CEE COSMA SOPE LTD. | 117 | 14.2 | 2.08 | 8.7 | 14.8 | 19.7 | — | 4.0 |
| YUVRAAJ HYGIENE PRODUCTS LTD. | 71 | 15.6 | 15.80 | — | 74.0 | 21.6 | — | 16.1 |
| AMBICA AGAR & AROMAINDLTD | 38 | 11.2 | 0.34 | — | 3.1 | 2.4 | — | 20.9 |
Exhibit 5: Where the company sits in its group
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 17.3 | 16.5 | 5 of 8 | 43% |
| P/B | 3.1 | 2.6 | 6 of 10 | 44% |
| ROCE | 22.4 | 11.6 | 1 of 10 | 100% |
| ROE | 18.1 | 8.6 | 3 of 10 | 78% |
| Debt / Equity | 0.0 | 0.1 | 1 of 10 | 89% |
| EBITDA margin | 18.5 | 10.5 | 3 of 10 | 78% |
| Revenue growth | 1.1 | 7.1 | 7 of 10 | 33% |
| Profit growth | (2.4) | 34.8 | 7 of 10 | 33% |
| Market cap | 6419 | 145 | 1 of 10 | 100% |
Exhibit 6: Filings of the last 90 days, with the measured price reaction
| Date · filing | Category | Importance | Next day % | 5-day % |
|---|---|---|---|---|
| 14 Oct 2026 · Q2FY27 results conference call scheduled for November 4, 2026 | board shareholder meetings | low | — | — |
| 13 Oct 2026 · Board meeting on Nov 4 to consider Q2 and H1 FY26 results | results | low | — | — |
| 8 Oct 2026 · Routine compliance certificate for share dematerialisation filed with stock exchanges | compliance | minimal | — | — |
| 5 Oct 2026 · Allotment of 21,009 equity shares under RSU Plan 2023 | capital market events | low | — | — |
| 29 Sept 2026 · Jyothy Labs receives insurance payout for Patiala warehouse fire | capex operations | high | — | — |
| 28 Sept 2026 · Trading window closure for Q2 FY27 results period | compliance | minimal | — | — |
| 25 Sept 2026 · CARE reaffirms AA Stable rating on Jyothy Labs Rs 250 cr bank facilities | credit debt | medium | — | — |
| 15 Sept 2026 · Jyothy Labs to hold one-on-one investor meet with Pari Washington on Sept 25 | board shareholder meetings | low | — | — |
| 15 Sept 2026 · Jyothy Labs schedules one-on-one meet with Nalanda Capital on Sept 23 | board shareholder meetings | low | — | — |
| 15 Sept 2026 · Jyothy Labs to host one-on-one meet with KC Capital on Sept 18 | board shareholder meetings | low | — | — |
How to read this document
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.